High-Grade Glioma, NOS — Trials

High-Grade Glioma, NOS — Trials · CancerIndex

Clinical trials

Registered studies

173 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 75
Recruiting: 47
Ph III recruiting: 1
Growth YoY: —
Industry share: 29%
Top sponsor: Nationwide Children's Hospital
Termination share: 44.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (30)

clinicaltrialsPublishedShowing 1–13 of 13 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07416188	Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma	recruiting	Phase 1 / Phase 2	40	National Institute of Neurological Disorders and Stroke (NINDS)NIH	1	Sep 28, 2026	clinicaltrials
NCT06161974	Study of Olutasidenib and Temozolomide in HGG	recruiting	Phase 2	60	Rigel PharmaceuticalsINDUSTRY	7	Sep 1, 2026	clinicaltrials